Brian Mac Grory
Duke University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Brian Mac Grory as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:00 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07493577 · Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)Dr David Hasan, M.D. · not yet recruiting · Aneurysmal Subarachnoid Hemorrhage · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Cardioembolism as a Mechanism of Central Retinal Artery OcclusionK23HL161426 · NHLBI · DUKE UNIVERSITY · fiscal years 2022 to 2026 · $163,333 awarded in 2026Same name and institution; not confirmed by an ID
- Induced Suppression of Platelet Activity in Aneurysmal SAH Management-2 (iSPASM-2)UH3NS138219 · NINDS · DUKE UNIVERSITY · fiscal years 2026 · $785,816 awarded in 2026Same name and institution; not confirmed by an ID
- Examining The Interplay Between Atrial Fibrillation, Anticoagulation, and Retinal Stroke - An Instrumental Variable ApproachR03HL178686 · NHLBI · DUKE UNIVERSITY · fiscal years 2025 · $242,250 awarded in 2025Same name and institution; not confirmed by an ID
- Induced Suppression of Platelet Activity in Aneurysmal SAH Management-2 (iSPASM-2)UG3NS138219 · NINDS · DUKE UNIVERSITY · fiscal years 2025 · $817,591 awarded in 2025Grant number is on one of their registry trials
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.